When immunotherapy bleeds: severe hemorrhagic gastritis secondary to pembrolizumab
DOI:
https://doi.org/10.15403/jgld-6324Keywords:
pembrolizumab, gastritis, Immune-related adverse events, hematemesisDownloads
Published
2025-09-26
How to Cite
1.
Alp J, Karna R, Amin K, Sloan JA. When immunotherapy bleeds: severe hemorrhagic gastritis secondary to pembrolizumab. JGLD [Internet]. 2025 Sep. 26 [cited 2026 Apr. 26];34(3):413-4. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/6324
Issue
Section
Letters
License
Copyright (c) 2025 Journal of Gastrointestinal and Liver Diseases

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

